Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis Wins Historic FDA Nod, Prices CAR-T For Leukemia at $475,000
Novartis Wins Historic FDA Nod, Prices CAR-T For Leukemia at $475,000
Novartis Wins Historic FDA Nod, Prices CAR-T For Leukemia at $475,000
Submitted by
admin
on August 30, 2017 - 11:48pm
Source:
Xconomy
News Tags:
Novartis
FDA
CAR-T
drug pricing
Kymriah
acute lymphoblastic leukemia
Headline:
Novartis Wins Historic FDA Nod, Prices CAR-T For Leukemia at $475,000
Do Not Allow Advertisers to Use My Personal information
